The decrease of NAD(P)H:quinone oxidoreductase 1 activity and increase of ROS production by NADPH oxidases are early biomarkers in doxorubicin cardiotoxicity


Autoria(s): Lagoa, Ricardo; Gañán, Carlos; López-Sánchez, Carmen; García-Martínez, Virginio; Gutierrez-Merino, Carlos
Data(s)

05/01/2017

05/01/2017

2014

Resumo

info:eu-repo/semantics/publishedVersion

Identificador

1366-5804

http://hdl.handle.net/10400.8/2352

10.3109/1354750X.2014.885084

Idioma(s)

eng

Publicador

Taylor & Francis

Relação

http://www.tandfonline.com/doi/abs/10.3109/1354750X.2014.885084

Direitos

openAccess

Palavras-Chave #Cellular bioenergetics #NQO1 #Cardiomyopathy #Oxidative stress #Anthracycline #Lipid oxidation #Research Subject Categories::NATURAL SCIENCES::Biology::Cell and molecular biology::Toxicology #Research Subject Categories::MEDICINE::Physiology and pharmacology #Research Subject Categories::MEDICINE::Morphology, cell biology, pathology #Research Subject Categories::MEDICINE::Chemistry::Biochemistry
Tipo

article